Cancer Research Meeting Calendar  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 2825-2831, May 15, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boyd, D.
Right arrow Articles by Brattain, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boyd, D.
Right arrow Articles by Brattain, M. G.

Alterations of the Biological Characteristics of a Colon Carcinoma Cell Line by Colon-derived Substrata Material1

Douglas Boyd, Germaine Florent, Subhas Chakrabarty, Diane Brattain and Michael G. Brattain2

Department of Pharmacology, Bristol-Baylor Laboratory, Baylor College of Medicine, Houston, TX 77030

This study documents the ability of substrata material derived from well but not poorly differentiated colon carcinoma cells to alter the biological characteristics of a separate colon carcinoma cell line (MOSERSF). To assess changes induced by the presence of these substrata, MOSERSF cells were screened for (a) morphological features, (b) secretion of carcinoembryonic antigen (CEA), (c) alteration of urokinase levels, and (d) sensitivity to the growth-inhibitory peptide transforming growth factor ß. Morphologically, MOSERSF cells grown on plastic displayed a rounded shape and could be detached by agitation. Subculturing of these cells onto substrata laid down by well differentiated (mature) colon carcinoma cells resulted in cell attachment and spreading. These changes did not manifest themselves when cells were plated on material derived from poorly differentiated (primitive) colon cells.

Conditioned medium from MOSERSF cells grown on plastic or on colon-derived material from the well and poorly differentiated colon cells were compared for CEA levels. Substrata derived from undifferentiated cells were without effect on assayable CEA (substrata absent, 1.4 ng/ml/106 cells/72 h; substrata present, 1.4–1.7 ng/ml/106 cells/72 h). However, growth of MOSERSF cells on material deposited by well differentiated colon cells resulted in a 3-fold increase in the level of CEA.

Spent medium was also analyzed for urokinase. A high level of the protease (20.3 ng/ml/106 cells/72 h) was expressed by MOSERSF cells. The concentration of the enzyme was reduced by over 50% when MOSERSF cells were propagated on substrata laid down by well differentiated cells.

An enhanced sensitivity to the growth-retarding effects of transforming growth factor ß was seen with certain substrata. On plastic, transforming growth factor ß inhibited proliferation of MOSERSF cells with a median effective concentration of 0.65 ng/ml. However, on substrata from mature but not primitive cells, MOSERSF cells exhibited an increased sensitivity to the peptide (median effective concentration, 0.16 ng/ml).

Colon-derived material obtained from both well differentiated and poorly differentiated colon carcinoma cells was compared after [35S]methionine metabolic labeling. More [35S]methionine was incorporated into the material from the "mature" colon cells. The substrata could also be distinguished by quantitative differences in a number of high molecular weight proteins. Immunofluorescence of colon-deposited material revealed the presence of laminin and fibronectin.

1 This work was supported by NIH Grant CA34432.

2 To whom requests for reprints should be addressed.

Received 8/10/87. Revised 12/ 2/87. Revised 2/16/88. Accepted 2/23/88.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. McTiernan, C.Y. Wang, B. Sorensen, L. Xiao, D. S.M. Buist, E. J. Aiello Bowles, E. White, M. A. Rossing, J. Potter, and N. Urban
No Effect of Aspirin on Mammographic Density in a Randomized Controlled Clinical Trial
Cancer Epidemiol. Biomarkers Prev., May 1, 2009; 18(5): 1524 - 1530.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Wang, G.-h. Zhou, T. M. Birkenmeier, J. Gong, L. Sun, and M. G. Brattain
Autocrine Transforming Growth Factor [IMAGE][IMAGE] Modulates the Expression of Integrin [IMAGE][IMAGE][IMAGE][IMAGE] in Human Colon Carcinoma FET Cells
J. Biol. Chem., June 9, 1995; 270(23): 14154 - 14159.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
T. W. Grunt, C. Somay, H. Oeller, E. Dittrich, and C. Dittrich
Comparative analysis of the effects of dimethyl sulfoxide and retinoic acid on the antigenic pattern of human ovarian adenocarcinoma cells
J. Cell Sci., October 1, 1992; 103(2): 501 - 509.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.